A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"?
Rastegarpanah
Mansoor
M
Digestive Disease Research Center, Medical Science/University of Tehran, Shariati Hospital, Kargar Shomali Ave, Tehran, Iran.
Malekzadeh
Fatemeh
F
Thomas
G Neil
GN
Mohagheghi
Abbas
A
Cheng
K K
KK
Marshall
Tom
T
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001241:Aspirin / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D004338:Drug Combinations; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D009203:Myocardial Infarction / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011322:Primary Prevention
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin